Nevertheless, the role of LDH as a prognostic biomarker in melanoma patients treated with anti-PD-1/PD-L1 antibodies is still a matter of debate, given that some studies indicate no significant link between LDH levels before treatment and OS/PFS. The gene discussed is CD274; the disease is melanoma.